Search
Investors
Careers
Investors
Careers
Company
Our Story
Leadership & Advisors
Pillar News
Distribution Partners
Strategic Partnership
Technology
Products
Portfolio Overview
IVD Products
Solid Tumor Tissue
Liquid Biopsy
Heme
BRCA, HRD, Methylation
InheritRevealâ„¢ Disease
Pharma
Resources
Resource Overview
Webinars and Presentations
Publications
Posters
Contact
Company
Our Story
Leadership & Advisors
Pillar News
Distribution Partners
Strategic Partnership
Technology
Products
Portfolio Overview
IVD Products
Solid Tumor Tissue
Liquid Biopsy
Heme
BRCA, HRD, Methylation
InheritRevealâ„¢ Disease
Pharma
Resources
Resource Overview
Webinars and Presentations
Publications
Posters
Contact
Company
Our Story
Leadership & Advisors
Pillar News
Distribution Partners
Strategic Partnership
Technology
Products
Portfolio Overview
IVD Products
Solid Tumor Tissue
Liquid Biopsy
Heme
BRCA, HRD, Methylation
Inherited Disease
Pharma
Resources
Resource Overview
Webinars and Presentations
Publications
Posters
Contact
Careers
Investors
Company
Our Story
Leadership & Advisors
Pillar News
Distribution Partners
Strategic Partnership
Technology
Products
Portfolio Overview
IVD Products
Solid Tumor Tissue
Liquid Biopsy
Heme
BRCA, HRD, Methylation
Inherited Disease
Pharma
Resources
Resource Overview
Webinars and Presentations
Publications
Posters
Contact
Careers
Investors
Presentations
The Simple Verifiation in a Molecular Pathology Lab of the FDA Approved oncoReveal CDx Pan-Cancer Solid Tumor IVD Assay
Event Name:
AMP 2024
TBC
Tags
Resource Topic
IVD
|
Solid Tumor
Year
2024